Cargando…
Role of antibody engineering in generation of derivatives starting from MOv19 MAb: 40 years of biological/therapeutic tools against folate receptor alfa
In the 1980s, we developed and characterized numerous murine monoclonal antibodies (MAbs) directed against human tumor-associated antigens. This mini review is focused on the generation of derivatives of an anti-folate receptor α (FRα) MAbs, named MOv19, exploiting the antibody-engineering progresse...
Autores principales: | Frigerio, Barbara, Montermini, Matilde, Silvana, Canevari, Figini, Mariangela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743174/ https://www.ncbi.nlm.nih.gov/pubmed/36518225 http://dx.doi.org/10.1093/abt/tbac026 |
Ejemplares similares
-
Validity of Anti-PSMA ScFvD2B as a Theranostic Tool: A Narrative-Focused Review
por: Frigerio, Barbara, et al.
Publicado: (2021) -
Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trial
por: Spicer, James, et al.
Publicado: (2023) -
Targeting folate receptor alpha for cancer treatment
por: Cheung, Anthony, et al.
Publicado: (2016) -
Folate receptors and transporters: biological role and diagnostic/therapeutic targets in cancer and other diseases
por: Frigerio, Barbara, et al.
Publicado: (2019) -
Broad-Spectrum Inhibition of HIV-1 by a Monoclonal Antibody Directed against a gp120-Induced Epitope of CD4
por: Burastero, Samuele E., et al.
Publicado: (2011)